These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38632084)

  • 1. TransGEM: a molecule generation model based on Transformer with gene expression data.
    Liu Y; Yu H; Duan X; Zhang X; Cheng T; Jiang F; Tang H; Ruan Y; Zhang M; Zhang H; Zhang Q
    Bioinformatics; 2024 May; 40(5):. PubMed ID: 38632084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Domenico A; Nicola G; Daniela T; Fulvio C; Nicola A; Orazio N
    J Chem Inf Model; 2020 Oct; 60(10):4582-4593. PubMed ID: 32845150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative Pre-trained Transformer (GPT) based model with relative attention for de novo drug design.
    Haroon S; C A H; A S J
    Comput Biol Chem; 2023 Oct; 106():107911. PubMed ID: 37450999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HELM-GPT: de novo macrocyclic peptide design using generative pre-trained transformer.
    Xu X; Xu C; He W; Wei L; Li H; Zhou J; Zhang R; Wang Y; Xiong Y; Gao X
    Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38867692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DrugGen: a database of de novo-generated molecular binders for specified target proteins.
    Qian H; Zhou J; Tu S; Xu L
    Database (Oxford); 2023 Dec; 2023():. PubMed ID: 38150626
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Matsukiyo Y; Yamanaka C; Yamanishi Y
    J Chem Inf Model; 2024 Apr; 64(7):2345-2355. PubMed ID: 37768595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design.
    Wang Q; Wei Z; Hu X; Wang Z; Dong Y; Liu H
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37971970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo drug design based on patient gene expression profiles via deep learning.
    Yamanaka C; Uki S; Kaitoh K; Iwata M; Yamanishi Y
    Mol Inform; 2023 Aug; 42(8-9):e2300064. PubMed ID: 37475603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DrugEx v3: scaffold-constrained drug design with graph transformer-based reinforcement learning.
    Liu X; Ye K; van Vlijmen HWT; IJzerman AP; van Westen GJP
    J Cheminform; 2023 Feb; 15(1):24. PubMed ID: 36803659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GraphormerDTI: A graph transformer-based approach for drug-target interaction prediction.
    Gao M; Zhang D; Chen Y; Zhang Y; Wang Z; Wang X; Li S; Guo Y; Webb GI; Nguyen ATN; May L; Song J
    Comput Biol Med; 2024 May; 173():108339. PubMed ID: 38547658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based
    Ma B; Terayama K; Matsumoto S; Isaka Y; Sasakura Y; Iwata H; Araki M; Okuno Y
    J Chem Inf Model; 2021 Jul; 61(7):3304-3313. PubMed ID: 34242036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm.
    Bai Q; Tan S; Xu T; Liu H; Huang J; Yao X
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32778891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing reinforcement learning for de novo molecular design applying self-attention mechanisms.
    Pereira TO; Abbasi M; Arrais JP
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37903414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target2DeNovoDrug: a novel programmatic tool for
    Madaj R; Geoffrey B; Sanker A; Valluri PP
    J Biomol Struct Dyn; 2022 Oct; 40(16):7511-7516. PubMed ID: 33703998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacophore-guided deep learning approach for bioactive molecular generation.
    Zhu H; Zhou R; Cao D; Tang J; Li M
    Nat Commun; 2023 Oct; 14(1):6234. PubMed ID: 37803000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cMolGPT: A Conditional Generative Pre-Trained Transformer for Target-Specific De Novo Molecular Generation.
    Wang Y; Zhao H; Sciabola S; Wang W
    Molecules; 2023 May; 28(11):. PubMed ID: 37298906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CProMG: controllable protein-oriented molecule generation with desired binding affinity and drug-like properties.
    Li JN; Yang G; Zhao PC; Wei XX; Shi JY
    Bioinformatics; 2023 Jun; 39(39 Suppl 1):i326-i336. PubMed ID: 37387157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.